| Literature DB >> 30684969 |
Nicholas Sajko1,2, Shannon Murphy3,4, Allen Tran5,4.
Abstract
BACKGROUND: Fever of unknown origin is often a diagnostic dilemma for clinicians due to its extremely broad differential. One of the rarer categories of disease causing fever of unknown origin is malignancies; of these, soft tissue sarcoma is one of the least common. Soft tissue sarcomas make up < 1% of all adult malignancies and often do not present with any systemic manifestations or neoplastic fevers. CASEEntities:
Keywords: Complex; Fever of unknown origin (FUO); Malignancy; Rare; Sarcoma; Soft tissue
Mesh:
Year: 2019 PMID: 30684969 PMCID: PMC6348079 DOI: 10.1186/s13256-018-1951-1
Source DB: PubMed Journal: J Med Case Rep ISSN: 1752-1947
Factors and exposures currently believed to be related to the development of various sarcoma subtypes
| Risk factors | |
|---|---|
| Environmental exposure | Ionizing radiation exposure |
| Phenoxyacetic acids | |
| Chlorophenol | |
| Vinyl chloride | |
| Dioxins | |
| Infectious agents | HIV |
| HHV8 | |
| Genetic conditions | Li–Fraumeni syndrome |
| Neurofibromatosis type 1 | |
| Retinoblastoma (13q14) | |
| Paget disease | |
| Werner syndrome | |
| Bloom syndrome | |
| Gardner syndrome | |
HHV8 human herpesvirus 8, HIV human immunodeficiency virus
Anatomic distribution of soft tissue sarcomas reported by the Memorial Sloan Kettering Cancer Center (MSKCC) between 1982 and 2011 (n = 9040)
| Site distribution | |
|---|---|
| Lower extremities | 29% |
| Visceral | 22% |
| Retroperitoneum | 16% |
| Other | 12% |
| Upper extremities | 11% |
| Trunk | 10% |
Subtypes of fever of unknown origin as defined by Durack and Street (1991) [6]
| FUO subtype | Definition | Major causes |
|---|---|---|
| Classical FUO | - Temperature of ≧ 38.3 °C | Malignancies, infections, inflammatory diseases (non-infectious) |
| Hospital acquired FUO | - Temperature of ≧ 38.3 °C | HAIs, postoperative complications, drug-induced |
| Immunocompromised or neutropenic FUO | - Temperature of ≧ 38.3 °C | Various bacterial, viral, and fungal infections |
| HIV-related FUO | - Temperature of ≧ 38.3 °C | HIV defining infections ( |
CMV cytomegalovirus, FUO fever of unknown origin, HAIs hospital acquired infections, HIV human immunodeficiency virus, IRIS immune reconstitution inflammatory syndrome. (Adapted from table presented in Hayakawa et al., 2012 [5])
Results of laboratory investigations conducted as part of the workup for the patient described
| Test | Results |
|---|---|
| White blood count (4.5–11.0 × 109/L) | 11.9 × 109/L |
| Hemoglobin (120–160 g/L) | 125 g/L (decreased to 109 g/L by discharge) |
| Mean corpuscular volume (80.0–97.0 fL) | 87.5 fL |
| Platelet count (150–350 × 109/L) | 373 × 109/L |
| Sodium (136–145 mmol/L) | 142 mmol/L |
| Potassium (3.4–5.0 mmol/L) | 4.7 mmol/L |
| Ionized calcium (1.15–1.27 mmol/L) | 1.16 mmol/L |
| Creatinine (49–90 μmol/L) | 60 μmol/L |
| Alanine aminotransferase (0–44 U/L) | 44 U/L |
| Aspartate aminotransferase (5–45 U/L) | 37 U/L |
| Alkaline phosphatase (38–150 U/L) | 179 U/L |
| Gamma glutamyltransferase (0–49 U/L) | 84 U/L |
| Total bilirubin (0.0–20.4 μmol/L) | 11.0 μmol/L |
| Albumin (35–50 g/L) | 24 g/L |
| Random glucose (3.9–7.8 mmol/L) | 5.5 mmol/L |
| C-reactive protein (0–7.99 mg/L) | 153.81 mg/L |
| Ferritin (6.5–204.0 μg/L) | 883.7 μg/L |
| Lactate dehydrogenase (120–230 U/L) | 203 U/L |
| Thyroid-stimulating hormone (0.35–4.30 mIU/L) | 0.84 mIU/L |
| Creatine kinase (30–200 U/L) | 49 U/L |
| Antinuclear antibody | Below detectable limits |
Fig. 1Ultrasound imaging of left thigh mass. Mass outlined with dashed white line
Fig. 2Magnetic resonance imaging investigation of left thigh mass. a Coronal magnetic resonance image of thighs. b Cross-sectional image of left thigh
Fig. 3Case report timeline of events. BP blood pressure, bpm beats per minute, CRP C-reactive protein, CT computed tomography, ED emergency department, HR heart rate, MRI magnetic resonance imaging, RA room air, Sat saturation, T temperature
Initial investigations in classical fever of unknown origin
| Diagnostic test | Potential diagnostic utility |
|---|---|
| Initial investigations | |
| CBC with differential and smear | - Neutropenia to determine breadth of possible infection, cytopenias suggesting bone marrow involvement |
| Renal function | - Glomerulonephritis |
| Liver enzymes and LFTs | - Hepatic or cholestatic etiologies |
| ESR and CRP | - Markers signifying an inflammatory process |
| Thyroid function | - Thyrotoxicosis |
| HIV antibody | - HIV and potential for opportunistic infections |
| Blood cultures | - Bacteremia or fungemia |
| Urine analysis and microscopy | - UTI, glomerulonephritis, or vasculitis |
| CXR | - Pneumonia, miliary TB, sarcoidosis, or malignancy |
| Investigations based on diagnostic clues from initial workup | |
| Echocardiography | - Potential endocarditis |
| CT | - Abscesses, other infections, or malignancy |
| Indium-111-WBC scan | - To localize any sites of inflammation |
| FDG-PET/CT | - Careful localization of infection, malignancy, vasculitis, or sarcoidosis |
| Lymph node biopsy | - Malignancy or infection |
| Liver biopsy | - Malignancy, infection, or autoimmune diseases |
| Bone marrow biopsy | - Hematologic malignancy |
| Temporal artery biopsy | - Giant cell arteritis |
CBC complete blood count, CRP C-reactive protein, CT computed tomography, CXR chest X-ray, ESR erythrocyte sedimentation rate, FDG fluorine-18-fluorodeoxyglucose, HIV human immunodeficiency virus, LFT liver function test, PET positron emission tomography, TB tuberculosis, UTI urinary tract infection, WBC white blood cell